Synektik Spólka Akcyjna (SNT.WA)
PLN 229.6
(1.41%)
PLN 229.6
(1.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 146.03 Million PLN | -1.75% |
| 2022 | 148.63 Million PLN | 87.84% |
| 2021 | 79.12 Million PLN | 20.59% |
| 2020 | 65.61 Million PLN | 19.65% |
| 2019 | 54.84 Million PLN | 17.69% |
| 2018 | 46.6 Million PLN | -12.92% |
| 2017 | 53.51 Million PLN | 58.26% |
| 2016 | 33.81 Million PLN | -29.35% |
| 2015 | 47.85 Million PLN | -1.25% |
| 2014 | 48.46 Million PLN | -1.46% |
| 2013 | 49.18 Million PLN | 12.05% |
| 2012 | 43.89 Million PLN | 36.55% |
| 2011 | 32.14 Million PLN | 252.04% |
| 2010 | 9.13 Million PLN | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 168.17 Million PLN | -20.28% |
| 2024 Q3 | 179.19 Million PLN | 6.56% |
| 2024 Q1 | 210.94 Million PLN | 44.45% |
| 2023 Q3 | 142.02 Million PLN | 5.36% |
| 2023 Q1 | 127.64 Million PLN | -14.12% |
| 2023 Q2 | 134.8 Million PLN | 5.61% |
| 2023 FY | 146.03 Million PLN | -1.75% |
| 2023 Q4 | 146.03 Million PLN | 2.82% |
| 2022 Q1 | 83.61 Million PLN | 5.68% |
| 2022 Q4 | 148.63 Million PLN | 26.43% |
| 2022 Q3 | 117.56 Million PLN | 1.31% |
| 2022 Q2 | 116.03 Million PLN | 38.77% |
| 2022 FY | 148.63 Million PLN | 87.84% |
| 2021 Q2 | 56.96 Million PLN | -9.22% |
| 2021 FY | 79.12 Million PLN | 20.59% |
| 2021 Q4 | 79.12 Million PLN | 35.72% |
| 2021 Q3 | 58.29 Million PLN | 2.34% |
| 2021 Q1 | 62.75 Million PLN | -4.37% |
| 2020 Q1 | 76.33 Million PLN | 39.18% |
| 2020 Q4 | 65.61 Million PLN | 38.11% |
| 2020 Q3 | 47.51 Million PLN | -30.63% |
| 2020 Q2 | 68.48 Million PLN | -10.28% |
| 2020 FY | 65.61 Million PLN | 19.65% |
| 2019 Q2 | 51.51 Million PLN | -34.55% |
| 2019 Q3 | 41.86 Million PLN | -18.74% |
| 2019 Q1 | 78.71 Million PLN | 36.21% |
| 2019 Q4 | 54.84 Million PLN | 31.01% |
| 2019 FY | 54.84 Million PLN | 17.69% |
| 2018 Q4 | 57.78 Million PLN | 18.08% |
| 2018 FY | 46.6 Million PLN | -12.92% |
| 2018 Q3 | 48.94 Million PLN | -2.2% |
| 2018 Q1 | 50.04 Million PLN | 25.93% |
| 2018 Q2 | 50.04 Million PLN | 0.0% |
| 2017 Q4 | 39.73 Million PLN | 28.98% |
| 2017 FY | 53.51 Million PLN | 58.26% |
| 2017 Q2 | 29.31 Million PLN | -13.31% |
| 2017 Q3 | 30.8 Million PLN | 5.11% |
| 2017 Q1 | 33.81 Million PLN | -7.93% |
| 2016 Q4 | 36.72 Million PLN | 9.1% |
| 2016 Q3 | 33.66 Million PLN | 2.98% |
| 2016 Q1 | 47.85 Million PLN | -5.46% |
| 2016 FY | 33.81 Million PLN | -29.35% |
| 2016 Q2 | 32.68 Million PLN | -31.7% |
| 2015 Q4 | 50.62 Million PLN | 103.77% |
| 2015 Q1 | 48.46 Million PLN | 4.52% |
| 2015 FY | 47.85 Million PLN | -1.25% |
| 2015 Q3 | 24.84 Million PLN | -28.85% |
| 2015 Q2 | 34.91 Million PLN | -27.95% |
| 2014 Q1 | 49.18 Million PLN | 6.7% |
| 2014 Q3 | 42.77 Million PLN | 9.59% |
| 2014 Q2 | 39.03 Million PLN | -20.63% |
| 2014 FY | 48.46 Million PLN | -1.46% |
| 2014 Q4 | 46.37 Million PLN | 8.4% |
| 2013 Q2 | 33.64 Million PLN | -23.35% |
| 2013 Q4 | 46.09 Million PLN | 60.87% |
| 2013 Q1 | 43.89 Million PLN | 44.69% |
| 2013 FY | 49.18 Million PLN | 12.05% |
| 2013 Q3 | 28.65 Million PLN | -14.84% |
| 2012 FY | 43.89 Million PLN | 36.55% |
| 2012 Q4 | 30.33 Million PLN | 29.75% |
| 2012 Q3 | 23.37 Million PLN | -12.02% |
| 2012 Q2 | 26.57 Million PLN | 0.0% |
| 2011 FY | 32.14 Million PLN | 252.04% |
| 2010 FY | 9.13 Million PLN | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Adiuvo Investments S.A. | 45.77 Million PLN | -218.997% |
| Genomtec S.A. | 4.45 Million PLN | -3181.584% |
| Medinice S.A. | 1.51 Million PLN | -9545.342% |
| Medicalgorithmics S.A. | 29.06 Million PLN | -402.427% |